JAGX vs. TPST, ANVS, CNSP, PYRGF, ELDN, VACC, ACRS, LABP, GNLX, and ALRN
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Tempest Therapeutics (TPST), Annovis Bio (ANVS), CNS Pharmaceuticals (CNSP), PyroGenesis Canada (PYRGF), Eledon Pharmaceuticals (ELDN), Vaccitech (VACC), Aclaris Therapeutics (ACRS), Landos Biopharma (LABP), Genelux (GNLX), and Aileron Therapeutics (ALRN). These companies are all part of the "pharmaceutical preparations" industry.
Jaguar Health (NASDAQ:JAGX) and Tempest Therapeutics (NASDAQ:TPST) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation.
Jaguar Health has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Comparatively, Tempest Therapeutics has a beta of -1.78, indicating that its share price is 278% less volatile than the S&P 500.
Tempest Therapeutics has lower revenue, but higher earnings than Jaguar Health.
Tempest Therapeutics has a net margin of 0.00% compared to Jaguar Health's net margin of -377.95%. Tempest Therapeutics' return on equity of -232.39% beat Jaguar Health's return on equity.
12.0% of Jaguar Health shares are owned by institutional investors. Comparatively, 22.5% of Tempest Therapeutics shares are owned by institutional investors. 0.0% of Jaguar Health shares are owned by insiders. Comparatively, 3.3% of Tempest Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Jaguar Health received 1742 more outperform votes than Tempest Therapeutics when rated by MarketBeat users. Likewise, 88.99% of users gave Jaguar Health an outperform vote while only 64.14% of users gave Tempest Therapeutics an outperform vote.
In the previous week, Tempest Therapeutics had 2 more articles in the media than Jaguar Health. MarketBeat recorded 3 mentions for Tempest Therapeutics and 1 mentions for Jaguar Health. Jaguar Health's average media sentiment score of 0.00 equaled Tempest Therapeutics'average media sentiment score.
Tempest Therapeutics has a consensus price target of $25.00, indicating a potential upside of 681.25%. Given Tempest Therapeutics' higher possible upside, analysts clearly believe Tempest Therapeutics is more favorable than Jaguar Health.
Summary
Tempest Therapeutics beats Jaguar Health on 8 of the 13 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
